Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension

被引:172
|
作者
Bauer, M [1 ]
Wilkens, HC
Langer, F
Schneider, SO
Lausberg, H
Schäfers, HJ
机构
[1] Univ Saarland, Dept Anesthesiol & Crit Care Med, D-66421 Homburg, Germany
[2] Univ Saarland, Dept Internal Med 5, D-66421 Homburg, Germany
[3] Univ Saarland, Dept Thorac & Cardiovasc Surg, D-66421 Homburg, Germany
关键词
pulmonary heart disease; hypertension; pulmonary; receptors;
D O I
10.1161/hc0902.105719
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The pulmonary circulation is an important site for the production and clearance of endothelin (ET)-1, a potent vasoactive and mitogenic peptide. Increased plasma ET-I levels are observed in pulmonary arterial hypertension (PHT) and may contribute to the regulation Of Pulmonary vascular resistance. as well as to proliferative changes in the pulmonary vascular bed. Methods and Results-We prospectively assessed changes in plasma big ET-1 levels and changes in ETA and ETB receptor gone expression in 14 consecutive patients undergoing pulmonary thromboendarterectomy for thromboembolic PHT. Plasma big ET-1 levels were higher in patients with PHT (median. 2.2 pg/mL; 25th to 75Lh percentile, 1.5 to 3.0 pg/mL) compared with age-matched controls (median. 1.2 pg/mL: 25th to 75th percentile, 1.0 to 1.4 pg/ml; P=0.002). In addition to increased plasma big ET-1 levels. selective upregulation of ETB, receptor mRNA transcripts and inimunoreactive protein in the pulmonary artery was observed in the patiems however, ETA receptor gene expression was unaffected. Conclusions-These data suggest that changes in the ET signaling system in PHT caused by thromboembolic disease are not limited to an increased production of ET-1: they also affect ET receptor gene expression.
引用
收藏
页码:1034 / 1036
页数:3
相关论文
共 50 条
  • [11] Sitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension
    Barst, Robyn J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (01) : 95 - 109
  • [12] Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan
    Barst, Robyn J.
    Langleben, David
    Badesch, David
    Frost, Adaani
    Lawrence, E. Clinton
    Shapiro, Shelley
    Naeije, Robert
    Galie, Nazzareno
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (10) : 2049 - 2056
  • [13] Endothelin receptor blockade in the management of pulmonary arterial hypertension: Selective and dual antagonism
    Trow, Terence K.
    Taichman, Darren B.
    RESPIRATORY MEDICINE, 2009, 103 (07) : 951 - 962
  • [14] Differential vasoactive response to Endothelin Receptor Antagonists and Prostacyclin in patients with severe pulmonary hypertension
    Kourgiannidis, G
    Manginas, A
    Apostolopoulou, S
    Webb, QJ
    Kyriakides, Z
    Rammos, S
    Kremastinos, D
    Cokkinos, DV
    EUROPEAN HEART JOURNAL, 2001, 22 : 321 - 321
  • [15] Differential vasoactive response to endothelin receptor antagonists and prostacyclin in patients with severe pulmonary hypertension
    Apostolopoulou, SC
    Kourgiannidis, G
    Manginas, A
    Kyriakides, ZS
    Webb, DJ
    Rammos, S
    Kremastinos, DT
    Cokkinos, DV
    CLINICAL SCIENCE, 2002, 103 : 298S - 301S
  • [16] \ Endothelin receptor antagonists for pulmonary arterial hypertension
    Bevacqua, Raul J.
    Bortman, Guillermo
    Perrone, Sergio V.
    INSUFICIENCIA CARDIACA, 2013, 8 (02) : 77 - 94
  • [17] Endothelin receptor antagonists in pulmonary arterial hypertension
    Channick, RN
    Sitbon, O
    Barst, RJ
    Manes, A
    Rubin, LJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) : 62S - 67S
  • [18] Endothelin receptor antagonists for pulmonary arterial hypertension
    Liu, Chao
    Chen, Junmin
    Gao, Yanqiu
    Deng, Bao
    Liu, Kunshen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (02):
  • [19] Low density lipoprotein induces upregulation of vasoconstrictive endothelin type B receptor expression
    Xu, Cang-Bao
    Zheng, Jian-Pu
    Zhang, Wei
    Liu, Enqi
    Edvinsson, Lars
    Zhang, Yaping
    VASCULAR PHARMACOLOGY, 2014, 60 (01) : 42 - 48
  • [20] Endothelin receptor antagonists for pulmonary arterial hypertension
    Liu, C
    Cheng, J
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01):